Reviewing The Case For Exelon Corp. (EXC) Going Higher

Currently, there are 999.00M common shares owned by the public and among those 998.00M shares have been available to trade.

The company’s stock has a 5-day price change of 1.98% and 4.68% over the past three months. EXC shares are trading 4.68% year to date (YTD), with the 12-month market performance down to -9.34% lower. It has a 12-month low price of $33.35 and touched a high of $43.71 over the same period. EXC has an average intraday trading volume of 7.10 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.07%, 5.37%, and -2.35% respectively.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Institutional ownership of Exelon Corp. (NASDAQ: EXC) shares accounts for 82.53% of the company’s 999.00M shares outstanding.

It has a market capitalization of $37.57B and a beta (3y monthly) value of 0.53. The stock’s trailing 12-month PE ratio is 16.09, while the earnings-per-share (ttm) stands at $2.34. The company has a PEG of 1.59 and a Quick Ratio of 0.73 with the debt-to-equity ratio at 1.71. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.50% over the week and 1.64% over the month.

Analysts forecast that Exelon Corp. (EXC) will achieve an EPS of $0.7 for the current quarter, $0.46 for the next quarter and $2.62 for 2025. The lowest estimate earnings-per-share for the quarter is $0.61 while analysts give the company a high EPS estimate of $0.72. Comparatively, EPS for the current quarter was $0.7 a year ago. Earnings per share for the fiscal year are expected to increase by 2.21%, and 7.76% over the next financial year. EPS should grow at an annualized rate of 10.10% over the next five years, compared to 2.40% over the past 5-year period.

Looking at the support for the EXC, a number of firms have released research notes about the stock. Mizuho stated their Buy rating for the stock in a research note on January 10, 2024, with the firm’s price target at $36-$39. UBS was of a view on January 02, 2024 that the stock is Neutral, while Morgan Stanley gave the stock Equal-Weight rating on December 18, 2023, issuing a price target of $45- $38. JP Morgan on their part issued Neutral rating on December 18, 2023.

Most Popular

Related Posts